Sign In
Get Clay Free →

Suggestions

    Tom Parker

    Partner, Pharmaceutical & Life Sciences Patent Litigation and Intellectual Property Transaction Group, Alston & Bird

    Professional Background

    Thomas Parker is a distinguished partner in the Intellectual Property Litigation and Transaction Group at Alston & Bird LLP, where he specializes in pharmaceutical patent litigation. With a career spanning nearly 30 years, Thomas has carved out a notable niche focusing on complex patent issues involving both the Hatch–Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA). His expertise is not limited to courtroom litigation; it extends to providing comprehensive legal counsel for pharmaceutical and biotechnology companies navigating the intricate landscape of patent and FDA regulatory matters related to the approval of generic, branded, and biosimilar drugs.

    In his role, Thomas has successfully represented clients as lead counsel in numerous high-stakes patent litigations and inter partes review proceedings before the Patent Trial and Appeal Board (PTAB). His insight and legal prowess have made him an essential advisor in actions concerning the FDA, helping clients understand their rights and obligations under various drug approval processes. Thomas's impressive track record demonstrates not only his skills as a litigator but also his commitment to advocating robustly for the interests of his clients in the pharmaceutical sector.

    In addition to litigation, Thomas's practice encompasses counseling clients on a wide variety of intellectual property matters, including patent prosecution, interference proceedings, and licensing across various scientific fields, ranging from pharmaceuticals to biotechnology and medical devices. As a prolific author and speaker, he often shares his insights on these subjects, contributing to the broader discourse on intellectual property in the life sciences field.

    Education and Achievements

    Thomas's educational background is a solid foundation for his career in intellectual property law. He earned his Juris Doctor (J.D.) degree in Intellectual Property Law from Seton Hall University School of Law, where he honed his legal acumen and developed a specialized focus that would fuel his professional journey. Prior to his studies in law, Thomas acquired a Master of Science (M.S.) in Microbiology and Biochemistry from the University of Massachusetts Amherst, further solidifying his understanding of the scientific principles that underpin his legal expertise. Earlier, he completed a Bachelor of Science (B.S.) in Microbiology at the same institution, establishing a comprehensive academic foundation critical to his future endeavors in the intersection of science and law.

    Throughout his career, Thomas has not only excelled in his practice but has also taken on pivotal roles in prestigious law firms. He co-founded A&B's Hatch–Waxman practice in 2003, showcasing his leadership capabilities and vision in the realm of patent litigation. Having served previously as Counsel at Coudert Brothers and Bryan Cave, and as an Associate at Brumbaugh Graves Donohue & Raymond, Thomas has accumulated a wealth of experience that equips him to face the diverse challenges of intellectual property law.

    Notable Achievements

    Some of Thomas Parker's most notable achievements include:

    • Successfully leading multiple patent litigations under the Hatch-Waxman Act in various high-profile cases that have reshaped the landscape of pharmaceutical patent law.
    • Co-founding and developing a nationally recognized Hatch-Waxman practice at Alston & Bird LLP, significantly enhancing the firm's reputation in pharmaceutical litigation.
    • Authoring informative publications and speaking at industry events, where he shares his extensive knowledge on intellectual property law, patent litigation, and FDA-related regulatory issues.
    • Registering to practice before the U.S. Patent and Trademark Office (U.S.P.T.O.), which underscores his commitment to maintaining the highest standards of professional legal practice in his field.

    In conclusion, Thomas Parker stands out in the field of intellectual property litigation with comprehensive legal expertise and a strong educational background in the sciences. Over the past 25 years, he has significantly impacted the pharmaceutical and biotechnology industries, providing invaluable counsel and representation in complex patent matters. As both a practitioner and thought leader, Thomas continues to contribute to advancements in patent law, helping to shape the future of intellectual property within the life sciences sector.

    Related Questions

    How did Thomas Parker gain his expertise in pharmaceutical patent litigation?
    What are some of the significant cases that Thomas Parker has led under the Hatch-Waxman Act?
    In what ways does Thomas Parker's background in science enhance his practice of intellectual property law?
    What inspired Thomas Parker to co-found A&B's Hatch–Waxman practice in 2003?
    How does Thomas Parker stay updated on the constantly evolving regulations related to FDA approvals in the pharmaceutical sector?
    Tom Parker
    Add to my network

    Location

    New York, New York, United States